News

Published on 15 Apr 2024 on Investing.com

Ani Pharmaceuticals executive sells shares worth over $16k By Investing.com


Article preview image

Following the sale, Cook still retains a significant stake in the company, with 59,731 shares of ANI...

NASDAQ.ANIP price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Earnings call: ANI Pharmaceuticals announced a 29% increase in total revenues By Investing.com

ANI Pharmaceuticals (NASDAQ:ANIP), Inc. (ANI) has announced a significant 29% year-over-year...

Investing.com 10 May 2024

Why Earnings Season Could Be Great for ANI Pharmaceuticals (ANIP)

Investors are always looking for stocks that are poised to beat at earnings season and ANI Pharma...

Zacks via Yahoo Finance 10 May 2024

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Stock Is Going Strong But Fundamentals Look Uncertain: What...

Most readers would already be aware that ANI Pharmaceuticals' (NASDAQ:ANIP) stock increased signi...

Simply Wall St. via Yahoo Finance 10 May 2024

Will Petrobras (PBR) Report Q1 Earnings Beat on Output Gains?

Petroleo Brasileiro S.A., or Petrobras PBR is set to release first-quarter 2024 results on May 13...

Zacks via Yahoo Finance 9 May 2024

CRISPR (CRSP) to Report Q1 Earnings: What's in the Cards?

We expect investors to focus on the initial sales numbers of CRISPR Therapeutics AG’s CRSP newly ...

Zacks via Yahoo Finance 7 May 2024

ANI Pharmaceuticals (ANIP) to Post Q1 Earnings: What's in Store?

ANI Pharmaceuticals ANIP is slated to report first-quarter 2024 results on May 10, before the ope...

Zacks via Yahoo Finance 7 May 2024

Ani Pharmaceuticals executive sells over $1.3 million in stock By Investing.com

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) has reported a significant stock transaction by one of it...

Investing.com 4 May 2024

Alkermes' (ALKS) Q1 Earnings & Revenues Fall Shy of Estimates

Alkermes plc ALKS reported adjusted earnings from continuing operations of 44 cents per share for...

Zacks via Yahoo Finance 3 May 2024

Repligen (RGEN) Q1 Earnings Miss, Revenues Beat Estimates

Repligen Corporation RGEN reported first-quarter 2024 adjusted earnings per share of 28 cents, wh...

Zacks via Yahoo Finance 3 May 2024

Kymera (KYMR) Q1 Loss Narrower Than Expected, Pipeline in Focus

Kymera Therapeutics, Inc. KYMR reported a loss of 69 cents per share in the first quarter of 2024...

Zacks via Yahoo Finance 3 May 2024